About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Global Shingles Vaccine Market Size, Top Share, Report to 2032
Shingles Vaccine Market

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI55647DR
Last Updated : July 24, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Market Segmentation

  1. Shingles Vaccine Market, By Product (2020-2032)
    1. Shingrix
    2. Zostavax
    3. SKYZoster
  2. Shingles Vaccine Market, By Vaccine Type (2020-2032)
    1. Recombinant Vaccine
    2. Live Attenuated Vaccine
    1. North America
      1. North America Shingles Vaccine Market, By Product
        1. Shingrix
          1. Zostavax
            1. SKYZoster
            2. North America Shingles Vaccine Market, By Vaccine Type
              1. Recombinant Vaccine
                1. Live Attenuated Vaccine
                2. U.S.
                  1. U.S. Shingles Vaccine Market, By Product
                    1. Shingrix
                      1. Zostavax
                        1. SKYZoster
                        2. U.S. Shingles Vaccine Market, By Vaccine Type
                          1. Recombinant Vaccine
                            1. Live Attenuated Vaccine
                          2. Canada
                        3. Europe
                          1. Europe Shingles Vaccine Market, By Product
                            1. Shingrix
                              1. Zostavax
                                1. SKYZoster
                                2. Europe Shingles Vaccine Market, By Vaccine Type
                                  1. Recombinant Vaccine
                                    1. Live Attenuated Vaccine
                                    2. U.K.
                                      1. U.K. Shingles Vaccine Market, By Product
                                        1. Shingrix
                                          1. Zostavax
                                            1. SKYZoster
                                            2. U.K. Shingles Vaccine Market, By Vaccine Type
                                              1. Recombinant Vaccine
                                                1. Live Attenuated Vaccine
                                              2. Germany
                                              3. France
                                              4. Spain
                                              5. Italy
                                              6. Russia
                                              7. Nordic
                                              8. Benelux
                                              9. Rest of Europe
                                            3. APAC
                                              1. APAC Shingles Vaccine Market, By Product
                                                1. Shingrix
                                                  1. Zostavax
                                                    1. SKYZoster
                                                    2. APAC Shingles Vaccine Market, By Vaccine Type
                                                      1. Recombinant Vaccine
                                                        1. Live Attenuated Vaccine
                                                        2. China
                                                          1. China Shingles Vaccine Market, By Product
                                                            1. Shingrix
                                                              1. Zostavax
                                                                1. SKYZoster
                                                                2. China Shingles Vaccine Market, By Vaccine Type
                                                                  1. Recombinant Vaccine
                                                                    1. Live Attenuated Vaccine
                                                                  2. Korea
                                                                  3. Japan
                                                                  4. India
                                                                  5. Australia
                                                                  6. Singapore
                                                                  7. Taiwan
                                                                  8. South East Asia
                                                                  9. Rest of Asia-Pacific
                                                                3. Middle East and Africa
                                                                  1. Middle East and Africa Shingles Vaccine Market, By Product
                                                                    1. Shingrix
                                                                      1. Zostavax
                                                                        1. SKYZoster
                                                                        2. Middle East and Africa Shingles Vaccine Market, By Vaccine Type
                                                                          1. Recombinant Vaccine
                                                                            1. Live Attenuated Vaccine
                                                                            2. UAE
                                                                              1. UAE Shingles Vaccine Market, By Product
                                                                                1. Shingrix
                                                                                  1. Zostavax
                                                                                    1. SKYZoster
                                                                                    2. UAE Shingles Vaccine Market, By Vaccine Type
                                                                                      1. Recombinant Vaccine
                                                                                        1. Live Attenuated Vaccine
                                                                                      2. Turkey
                                                                                      3. Saudi Arabia
                                                                                      4. South Africa
                                                                                      5. Egypt
                                                                                      6. Nigeria
                                                                                      7. Rest of MEA
                                                                                    3. LATAM
                                                                                      1. LATAM Shingles Vaccine Market, By Product
                                                                                        1. Shingrix
                                                                                          1. Zostavax
                                                                                            1. SKYZoster
                                                                                            2. LATAM Shingles Vaccine Market, By Vaccine Type
                                                                                              1. Recombinant Vaccine
                                                                                                1. Live Attenuated Vaccine
                                                                                                2. Brazil
                                                                                                  1. Brazil Shingles Vaccine Market, By Product
                                                                                                    1. Shingrix
                                                                                                      1. Zostavax
                                                                                                        1. SKYZoster
                                                                                                        2. Brazil Shingles Vaccine Market, By Vaccine Type
                                                                                                          1. Recombinant Vaccine
                                                                                                            1. Live Attenuated Vaccine
                                                                                                          2. Mexico
                                                                                                          3. Argentina
                                                                                                          4. Chile
                                                                                                          5. Colombia
                                                                                                          6. Rest of LATAM

                                                                                                      Related Reports

                                                                                                      Global Report
                                                                                                      Bispecific Antibodies Market Size The global bispecific antibodies market size was valued at USD 11.84 billion in 2024 and is expected to grow from USD 17.10 billion in 2025 to USD 323.21 billion by 2033, growing at a CAGR of 44.4% du
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      Bladder Scanners Market Size The global bladder scanners market size was valued at USD 149.28 million in 2024 and is projected to grow from USD 162.36 million in 2025 to reach USD 270.46 million by 2033, exhibiting a CA
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      Hair Removal Wax Market Size The global hair removal wax market size was valued at USD 14426.26 million in 2024 and is projected to reach from USD 15133.14 million in 2025 to USD 22188.76 million by 2033, growing at a CAGR of 4.9% during t
                                                                                                      Buy Now

                                                                                                      Purchase Benefits

                                                                                                      • Eligible for a free updated report next year
                                                                                                      • Completely customizable scope
                                                                                                      • 30% discount on your next purchase
                                                                                                      • Dedicated account manager
                                                                                                      • Query resolution within 24 hours
                                                                                                      • Permission to print the report

                                                                                                      We are featured on :

                                                                                                      www.straitsresearch.com
                                                                                                      © Copyright 2025. All rights Reserved.